Tilmicosin 300 mg is indicated for the treatment of respiratory infections in cattle and sheep
associated with Mannheimia haemolytica, Pasteurella spp. and other tilmicosin-susceptible
micro-organisms, and for the treatment of ovine mastitis associated with Staphylococcus aureus
and Mycoplasma spp.
Additional indications include the treatment of interdigital
necrobacillosis in cattle (bovine pododermatitis, foul in the
foot) and foot rot.